✦ LIBER ✦

Long-term side effects of azathioprine

✍ Scribed by Murray B. Urowitz; Duncan A. Gordon; Hugh A. Smythe; Waldemar Pruzanski; Metro A. Ogryzlo

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 139 KB
Volume: 17
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780170624

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Azathioprine in Behçet's syndrome. Effec

Azathioprine in Behçet's syndrome. Effects on long-term prognosis

✍ Vedat Hamuryudan; Yilmaz Özyazgan; Nail Hizli; Cem Mat; Sebahattin Yurdakul; Yal 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

Myasthenia gravis: Discontinuation of lo

Myasthenia gravis: Discontinuation of long-term azathioprine

✍ M. Michels; R. Hohlfeld; H.-P. Hartung; K. Heininger; U. A. Besinger; K. V. Toyk 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Prednisone and azathioprine for polymyos

Prednisone and azathioprine for polymyositis. Long-term followup

✍ Thomas W Bunch 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB 👁 1 views

Hypotension With Oliguria: a Side-Effect

Hypotension With Oliguria: a Side-Effect of Azathioprine

✍ Edward C. Keystone; Richard Schabas 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

Side effects of long-term oral antiviral

Side effects of long-term oral antiviral therapy for hepatitis B

✍ Robert J. Fontana 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

The aim of this review is to summarize the safety profile of the five approved oral nucleoside analogs used to treat chronic hepatitis B virus (HBV) infection, focusing on both the class adverse effects and those that have been reported with individual agents, as well as their safety in pregnancy. A

Long-term maintenance therapy with azath

Long-term maintenance therapy with azathioprine in systemic lupus erythematosus

✍ Ellen Ginzler; Ezra Sharon; Herbert Diamond; David Kaplan 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

## Abstract One hundred ten patients with systemic lupus erythematosus (SLE) were classified into two groups, patients with central nervous system (CNS) or severe renal disease (usually associated with a poor prognosis) and patients without these manifestations, to define criteria for azathioprine